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Two articles published recently in PLoS
Medicine highlight the problem of how to
effectively share information in the wake
of a rapidly spreading disease, and
prompted us to ask the question ‘‘How
well are journals doing?’’ with regard to
this important goal. The answer, sadly,
seems to be ‘‘not well enough.’’ Although
the potential of the Internet for improving
the dissemination of information is now
taken for granted, it would seem that the
attitudes of those involved in sharing this
information have not kept pace with the
technology. Accordingly, it is fair to ask
whether the flow of information in the face
of a crisis is truly enabled by publication in
medical journals (even online journals) or
whether we need new avenues for rapid
data sharing.
An article appearing this month in PLoS
Medicine by Weijia Xing and colleagues [1]
dissected the publication of a subset of
epidemiological papers during the severe
acute respiratory syndrome (SARS) epidem-
ic of 2003. Based on their findings, it would
be hard to conclude that journal publication
was a successful mechanism for rapidly
sharing information. As the authors note,
‘‘Only 22% of the studies were submitted,
8% accepted, and 7% published during the
epidemic.’’ What were the reasons behind
these findings? The authors argue that the
lack of standard methods for data collection
and manuscript preparation may have
played a part. In addition, despite journals’
best efforts to speed up times to publication
(reflected in shorter publication times com-
pared with control articles on unrelated
topics, submitted at the same time), the time
to publication was over 200 days for many
articles. It’s not possible to know whether
these delays were compounded by articles
being sequentially submitted to a number of
different journals before being published.
But it is notable that while the 311 SARS
articles were published in 137 different
journals, the first ten published studies
appeared in The Lancet (n=7) and The New
England Journal of Medicine (n=3). However,
the impact factors of journals publishing
articles on SARS decreased significantly as
time went on. Put another way, it seems that
at the beginning of the epidemic, high-
profile journals were willing to publish
papers on SARS, but their interest waned
rapidly. In addition, it is likely that, as with
publishing other types of article, authors will
try high-impact journals first.
Fast forward to the H1N1 pandemic of
2009–10. It’s too early to carry out the same
type of analysis that was done for SARS by
Xing et al., but a paper we published in
early April indicates that many of the same
problems remain. The paper, ‘‘Association
between the 2008–09 Seasonal Influenza
Vaccine and Pandemic H1N1 Illness dur-
ing Spring-Summer 2009: Four Observa-
tional Studies from Canada’’ [2] reports
potentially worrying findings about the
impact of seasonal flu vaccination on illness
from H1N1. We’re the first to admit we
were notquick—we receivedthepaper on 2
November 2009, accepted it on 1 March
2010, and published it on 6 April 2010. It’s
quite possible that this delay could have
exacerbated the problem of making deci-
sionsaboutvaccination forthepublichealth
physiciansand policymakerswhohadheard
informally about some of the results and
wondered if they should be changing
course. At the same time, the need for
careful review of these controversial data
meant that we could not rush the review
process. In addition, as the lead author,
Danuta Skowronski, herself indicated, prior
rejection from another journal added fur-
ther to the delay in publication [3].
Taken together these two papers high-
light an inherent limitation in the journal
publication system with regard to rapid
dissemination of results in a time of crisis:
the processes that ensure careful evalua-
tion come at the expense of immediate
dissemination.
Journals are, of course, only one source
of information for health and scientific
research, and may be over-relied upon,
especially in emergencies. International
bodies such as WHO provided efficient
regular [4] updates during both emergen-
cies, as did local health bodies such as the
Health Protection Agency in the UK [5]
and the Centers for Disease Control in the
US [6]. Face-to-face meetings and tele-
conferences provide further mechanisms
for sharing of information, and when
linked to sharing of resources were pow-
erful catalysts for accelerating influenza
research. PLoS itself launched an experi-
mental site, PLoS Currents: Influenza
(http://knol.google.com/k/plos-currents-
influenza#) for early sharing of informa-
tion after only the lightest of moderation.
Despite other mechanisms of dissemi-
nation (which need not preclude later
publication in more formal peer reviewed
journals) even in the face of a public health
emergency, authors seem tied to publish-
ing information first in peer-reviewed
journals, possibly because they may per-
ceive readers as reluctant to take results
seriously until they have successfully
emerged from review by a respected
journal. It seems therefore timely to ask
whether journals, and others involved in
publishing, are confusing the valid role of
a journal as a place of scientific record
with an equally valid role, that of a news
outlet? In a Canadian press report [3] on
the Skowronski paper, Ross Upshur, head
of the University of Toronto’s Joint Centre
for Bioethics, was quoted as saying ‘‘Mak-
ing public health policy during a pandemic
based on data most people hadn’t seen was
far from ideal,’’ adding that he believes the
question of when public health priorities
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mains to be resolved: ‘‘Putting the impri-
matur of a high impact peer review
journal first is I think what we need to
have the discussion about.’’
Of course, the authors of this paper, and
of all the articles published from study of
the SARS epidemic and the H1N1
pandemic, would say they were not
seeking such an ‘‘imprimatur’’ for the sake
of it, but because as yet there is no widely
accepted alternative to the ‘‘quality’’
stamp that peer review imparts. Similarly,
journal editors would maintain that high-
profile papers generated by such emer-
gencies need intense scrutiny lest the
public health suffer from the premature
publication of unreliable results.
But in the case of a public health
emergency, are these concerns enough to
override the need for information—any
information—however preliminary and
unconfirmed? Should the whole paradigm
of publishing be rethought in such in-
stances? In the age of blogs, Twitter, and
the 24-hour news cycle, are journals a
realistic avenue for rapid publication at
all? Instead, is there a role for data-
sharing—i.e., the news outlet function—
rather than traditional publication in an
emergency situation? If so, who would set
up data repositories and oversee them,
how would authors get academic credit for
their work, and how would readers and
reporters learn to interpret data presented
through such a system? Whatever the
answers may be, it seems clear that before
the next public health emergency strikes,
the scientific publishing establishment
needs to ask itself how it can respond in
the way the world needs.
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